AI Summary
This article discusses the development of NKT cell agonists with high potency and specific cytokine selectivity through hydrogen-bond interactions. The research focuses on designing molecules that can activate NKT cells in a controlled manner, potentially leading to improved therapeutic outcomes in various diseases. The use of hydrogen-bond interactions allows for precise modulation of cytokine production, which could have significant implications for the treatment of inflammatory conditions.